Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 145


Global vaccinology training: Report from an ADVAC workshop.

Duclos P, Martinez L, MacDonald N, Asturias E, Nohynek H, Lambert PH; all participants of the Global Vaccinology Training Workshop.

Vaccine. 2019 May 16;37(22):2871-2881. doi: 10.1016/j.vaccine.2019.02.062. Epub 2019 Mar 18.


Moving forward on strengthening and sustaining National Immunization Technical Advisory Groups (NITAGs) globally: Recommendations from the 2nd global NITAG network meeting.

MacDonald NE, Duclos P, Wichmann O, Henaff L, Harnden A, Alshammary A, Tijerino RA, Hall M, Sacarlal J, Singh RR.

Vaccine. 2017 Dec 15;35(50):6925-6930. doi: 10.1016/j.vaccine.2017.10.048. Epub 2017 Nov 2.


An update of the global burden of pertussis in children younger than 5 years: a modelling study.

Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW.

Lancet Infect Dis. 2017 Sep;17(9):974-980. doi: 10.1016/S1473-3099(17)30390-0. Epub 2017 Jun 13.


Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.

Adjagba A, MacDonald NE, Ortega-Pérez I, Duclos P; 2016 Global NITAG Network Meeting Participants.

Vaccine. 2017 May 25;35(23):3007-3011. doi: 10.1016/j.vaccine.2017.04.039. Epub 2017 Apr 26.


Off-label use of vaccines.

Neels P, Southern J, Abramson J, Duclos P, Hombach J, Marti M, Fitzgerald-Husek A, Fournier-Caruana J, Hanquet G.

Vaccine. 2017 Apr 25;35(18):2329-2337. doi: 10.1016/j.vaccine.2017.02.056. Epub 2017 Mar 22. Review.


Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns.

Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P.

PLoS One. 2017 Mar 1;12(3):e0172310. doi: 10.1371/journal.pone.0172310. eCollection 2017.


Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries.

Sobanjo-Ter Meulen A, Duclos P, McIntyre P, Lewis KD, Van Damme P, O'Brien KL, Klugman KP.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S123-S133. Review.


Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.

Perronne C, Adjagba A, Duclos P, Floret D, Houweling H, Le Goaster C, Lévy-Brühl D, Meyer F, Senouci K, Wichmann O.

Vaccine. 2016 Mar 8;34(11):1325-30. doi: 10.1016/j.vaccine.2016.01.063. Epub 2016 Feb 6.


New recommendations to prevent pain during immunizations: WHO position paper - September 2015.

Pottie K, Siu W, Duclos P; Members of the WHO Technical Consultation on Pain Mitigation.

Vaccine. 2016 Jul 12;34(32):3627-8. doi: 10.1016/j.vaccine.2015.11.064. Epub 2016 Jan 9. No abstract available.


The NITAG Resource Centre (NRC): One-stop shop towards a collaborative platform.

Adjagba A, Henaff L, Duclos P.

Vaccine. 2015 Aug 26;33(36):4365-7. doi: 10.1016/j.vaccine.2015.06.106. Epub 2015 Jul 10.


Review of vaccine hesitancy: Rationale, remit and methods.

Schuster M, Eskola J, Duclos P; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Aug 14;33(34):4157-60. doi: 10.1016/j.vaccine.2015.04.035. Epub 2015 Apr 18. Review.


How to deal with vaccine hesitancy?

Eskola J, Duclos P, Schuster M, MacDonald NE; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Aug 14;33(34):4215-7. doi: 10.1016/j.vaccine.2015.04.043. Epub 2015 Apr 18.


Towards a framework for evaluating and grading evidence in public health.

Harder T, Abu Sin M, Bosch-Capblanch X, Bruno Coignard, de Carvalho Gomes H, Duclos P, Eckmanns T, Elder R, Ellis S, Forland F, Garner P, James R, Jansen A, Krause G, Lévy-Bruhl D, Morgan A, Meerpohl JJ, Norris S, Rehfuess E, Sánchez-Vivar A, Schünemann H, Takla A, Wichmann O, Zingg W, Zuiderent-Jerak T.

Health Policy. 2015 Jun;119(6):732-6. doi: 10.1016/j.healthpol.2015.02.010. Epub 2015 Mar 23.


World health organization approaches to evaluating the potential use and quality of hepatitis e vaccine.

Harmanci H, Duclos P, Rodriguez Hernandez CA, Meek A, Balakrishnan MR, Kumar Arora N, Wiktor SZ.

Open Forum Infect Dis. 2014 Dec 2;1(3):ofu099. doi: 10.1093/ofid/ofu099. eCollection 2014 Dec. No abstract available.


The development of global vaccine stockpiles.

Yen C, Hyde TB, Costa AJ, Fernandez K, Tam JS, Hugonnet S, Huvos AM, Duclos P, Dietz VJ, Burkholder BT.

Lancet Infect Dis. 2015 Mar;15(3):340-7. doi: 10.1016/S1473-3099(14)70999-5. Epub 2015 Feb 6. Review.


Vaccine vigilance in Canada: Is it as robust as it could be?

Duclos P.

Can Commun Dis Rep. 2014 Dec 4;40(Suppl 3):2-6. eCollection 2014 Dec 4.


Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review.

Rafferty E, Duclos P, Yactayo S, Schuster M.

Vaccine. 2013 Dec 2;31(49):5798-805. doi: 10.1016/j.vaccine.2013.09.030. Epub 2013 Sep 27. Review.


Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.

Duclos P, Dumolard L, Abeysinghe N, Adjagba A, Janusz CB, Mihigo R, Mosina L, Takashima Y, Oztürk MH.

Vaccine. 2013 Nov 4;31(46):5314-20. doi: 10.1016/j.vaccine.2013.08.084. Epub 2013 Sep 20.


Assessment of the RTS,S/AS01 malaria vaccine.

Moorthy VS, Newman RD, Duclos P, Okwo-Bele JM, Smith PG.

Lancet Infect Dis. 2013 Apr;13(4):280-2. doi: 10.1016/S1473-3099(13)70047-1. Epub 2013 Mar 1. No abstract available.


Indicators to assess National Immunization Technical Advisory Groups (NITAGs).

Blau J, Sadr-Azodi N, Clementz M, Abeysinghe N, Cakmak N, Duclos P, Janusz C, Jauregui B, Mihigo R, Mosina L, Takashima Y, Senouci K.

Vaccine. 2013 May 28;31(23):2653-7. doi: 10.1016/j.vaccine.2013.01.047. Epub 2013 Feb 8.


Supplemental Content

Loading ...
Support Center